Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |  |
|---|---|
| Related links |  |
| Search |  |
Rchr
J-GLOBAL ID：202301004473644928
Update date: Apr. 08, 2025 Shibamoto Akihiko
シバモト アキヒコ | Shibamoto Akihiko
Clips
Nara Medical University
About Nara Medical University
Research theme for competitive and other funds (1)：
- 2024 - 2026 Pathophysiological analysis and therapeutic development based on vWF-ADAMTS13 regulation for poor prognostic factors in liver cirrhosis
- Yukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, Akihiko Shibamoto, Takahiro Kubo, Aritoshi Koizumi, Takuya Matsuda, Takashi Inoue, Satoshi Iwai, Fumimasa Tomooka, et al. Fibrosis stage is an independent predictor of liver-related complications in primary biliary cholangitis. Hepatology Research. 2025
- Jun-Ichi Hanatani, Koh Kitagawa, Fumimasa Tomooka, Shohei Asada, Akira Mitoro, Yukihisa Fujinaga, Norihisa Nishimura, Shinya Sato, Akihiko Shibamoto, Yuki Fujimoto, et al. Impact of the COVID-19 pandemic on the treatment of acute cholangitis caused by choledocholithiasis: A single-center retrospective study in Japan. DEN open. 2025. 5. 1. e371
- Akihiko Shibamoto, Tadashi Namisaki, Satoshi Iwai, Fumimasa Tomooka, Takahiro Kubo, Aritoshi Koizumi, Misako Tanaka, Takuya Matsuda, Takashi Inoue, Yuki Tsuji, et al. Prognostic significance of skeletal muscle mass in patients with alcohol-related cirrhosis. Hepatology Research. 2025
- Yuki Tsuji, Tadashi Namisaki, Hiroaki Takaya, Naoki Nishimura, Ryuichi Noguchi, Shohei Asada, Akihiko Shibamoto, Takahiro Kubo, Satoshi Iwai, Fumimasa Tomooka, et al. Risk Factors for Intrahepatic Distant Recurrence After Radiofrequency Ablation for Hepatocellular Carcinoma. Digestive diseases and sciences. 2025
- Satoshi Iwai, Takemi Akahane, Hiroaki Takaya, Takahiro Kubo, Fumimasa Tomooka, Akihiko Shibamoto, Junya Suzuki, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura, et al. Ratio of von Willebrand factor to ADAMTS13 is a useful predictor of esophagogastric varices progression after sustained virologic response in patients with hepatitis C virus-related liver cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
- 高見昌義, 高谷広章, 浪崎正, 岩井聡始, 久保貴裕, 芝本彰彦, 友岡文優, 辻裕樹, 藤永幸久, 北川洸, et al. Can VWF and ADAMTS13 be new biomarkers for hepatic arterial infusion chemotherapy for liver cancer?. 日本がん転移学会学術集会・総会プログラム抄録集. 2024. 33rd
- 浪崎 正, 芝本 彰彦, 竹田 惣一, 藤本 優樹, 榎本 壮秀, 村田 晃児, 辻 裕樹, 藤永 幸久, 西村 典久, 鍛治 孝祐, et al. 肝硬変の成因と病態の推移 当科における肝硬変の成因別実態と変遷. 肝臓. 2023. 64. Suppl.1. A263-A263
- 高見 昌義, 瓦谷 英人, 増田 泰之, 岩井 聡始, 久保 貴裕, 田中 美彩子, 芝本 彰彦, 依岡 伸幸, 榎本 壮秀, 藤本 優樹, et al. 小腸出血に対するバルーン内視鏡の意義. Gastroenterological Endoscopy. 2023. 65. Suppl.1. 881-881
- 友岡文優, 鍛治孝祐, 北川洸, 西村典久, 久保貴裕, 芝本彰彦, 岩井聡始, 鈴木淳也, 吉治仁志. スルフォラファンはHDAC阻害を介しゲムシタビンの肝内胆管癌抑制効果を増強させる. 日本消化器病学会雑誌(Web). 2023. 120
- 友岡文優, 鍛治孝祐, 北川洸, 西村典久, 久保貴裕, 芝本彰彦, 岩井聡始, 鈴木淳也, 辻裕樹, 藤永幸久, et al. Sulforaphane potentiates the cholangiocarcinoma inhibitory effect of gemcitabine via HDAC inhibition. 日本がん転移学会学術集会・総会プログラム抄録集. 2023. 32nd
- 2024/04 - 現在 奈良県立医科大学 消化器内科学 助教
- 2023/04 - 2024/03 Nara Medical University
- 2020/04 - 2024/03 Nara Medical University
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
